Anastasia A. Kovpak

Chumakov FSC R&D IBP RAS, Building 1, Village Of The Institute Of Poliomyelitis 8
Moscow, MOW 108819, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Inactivation of Wild Poliovirus with β-Propiolactone.

Inactivation of Wild Poliovirus with β-Propiolactone.

Journal: Vaccines
Published: June 05, 2026

Generation of Polyclonal Antibodies Against Sabin Poliovirus D- and H-Antigens and Their Application in ELISA.

Generation of Polyclonal Antibodies Against Sabin Poliovirus D- and H-Antigens and Their Application in ELISA.

Journal: Vaccines
Published: August 07, 2025

Degradation of Poliovirus Sabin 2 Genome After Electron Beam Irradiation.

Degradation of Poliovirus Sabin 2 Genome After Electron Beam Irradiation.

Journal: Vaccines
Published: June 09, 2025

Effect of inactivated whole-virion concentrated purified vaccine for the prevention of COVID-19 on clinical and biochemical blood parameters of immature rats

Effect of inactivated whole-virion concentrated purified vaccine for the prevention of COVID-19 on clinical and biochemical blood parameters of immature rats

Journal: Voprosy virusologii
Published: March 14, 2025

Electrochemical profiling of poliovirus particles inactivated by chemical method and ionizing radiation.

Electrochemical profiling of poliovirus particles inactivated by chemical method and ionizing radiation.

Journal: Biomeditsinskaia khimiia
Published: June 28, 2024

High-Throughput Sequencing Reveals Three Rhabdoviruses Persisting in the IRE/CTVM19 Cell Line.

High-Throughput Sequencing Reveals Three Rhabdoviruses Persisting in the IRE/CTVM19 Cell Line.

Journal: Viruses
Published: March 14, 2024

Perspectives for the creation of a new type of vaccine preparations based on pseudovirus particles using polio vaccine as an example.

Perspectives for the creation of a new type of vaccine preparations based on pseudovirus particles using polio vaccine as an example.

Journal: Biomeditsinskaia khimiia
Published: November 08, 2023

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts.

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts.

Journal: Viruses
Published: June 15, 2023

Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography.

Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography.

Journal: Vaccines
Published: April 25, 2022

Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence.

Vaccination With Oral Polio Vaccine Reduces COVID-19 Incidence.

Journal: Frontiers in immunology
Published: March 29, 2022

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.

Journal: Emerging microbes & infections
Published: August 24, 2021

Structural characterization of β-propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles.

Structural characterization of β-propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles.

Journal: Microscopy research and technique
Published: May 25, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026